Complexity in influenza virus targeted drug design: interaction with human sialidases.
about
Molecular insight into substrate recognition by human cytosolic sialidase NEU2Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activitySynthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylateTuning mechanism-based inactivators of neuraminidases: mechanistic and structural insightsThe catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealedPreventing and treating secondary bacterial infections with antiviral agentsPeramivir for the treatment of influenza.Recent advances in neuraminidase inhibitor development as anti-influenza drugs.The impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor design.The evolutionary pattern of glycosylation sites in influenza virus (H5N1) hemagglutinin and neuraminidase.Anti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressiveness.Synthetic Mucus Nanobarriers for Identification of Glycan-Dependent Primary Influenza A Infection Inhibitors.Application of NMR methods to the study of the interaction of natural products with biomolecular receptors.Carbohydrate-protein interactions: a 3D view by NMR.Influenza neuraminidase: a druggable target for natural products.The chemistry and biology of organic guanidine derivatives.Antibody against Microbial Neuraminidases Recognizes Human Sialidase 3 (NEU3): the Neuraminidase/Sialidase Superfamily Revisited.Clinical reasoning: an unexpected diagnosis in a 4-month-old infant with lethargy and H1N1 influenza.Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.synthesis and preliminary biologic evaluation of 5-substituted-2-(4-substituted phenyl)-1,3-benzoxazoles as a novel class of influenza virus A inhibitors.Novel pH-dependent regulation of human cytosolic sialidase 2 (NEU2) activities by siastatin B and structural prediction of NEU2/siastatin B complex.A simple synthesis of N-perfluoroacylated and N-acylated glycals of neuraminic acid with a cyclic aminic substituent at the 4α position as possible inhibitors of sialidases.Inhibition of influenza H5N1 invasion by modified heparin derivatives
P2860
Q24301390-063E069F-C48F-4CCA-90CC-423C7C032EF4Q27684054-4A02C46B-3FB2-4C37-8CEC-6522670A585AQ27688897-2190B98C-E4B6-4EA0-BAB6-ECB92DE9112BQ27689415-E5F77B4B-3BE9-4EC6-80BC-3F8B3F5EB4EBQ27697978-C243CBFB-573C-462B-8DEE-DEF36EFAA156Q30401260-2B0F1A8A-AF76-4181-A1A8-AB682B4F2045Q30413154-D3CAC224-C555-4F44-9CDB-5358B899224CQ30419301-8686B283-C79B-45F9-A89D-3627C43C227AQ33867041-71E9B625-4503-48C5-96C5-1362687BEA15Q34469957-E82F49E5-6AF2-42B1-B6AB-0C5EC27F923AQ35303234-96331DDB-EDAC-492D-B64F-6799CF136318Q37374096-5D571B97-A676-4DEB-A46F-F63E2D9777ADQ37864564-C68133AD-DBFC-4CE1-887B-45D53F17228FQ37866236-16F51A82-BF6F-4B34-A3E3-FF628641939FQ37949284-718B016D-57B5-4A2B-9DA4-ABDB09FD4D00Q38044691-6ACE857E-529A-47D3-80D1-A4BBAD2155F3Q40143403-F937E762-719C-403B-B887-F05B012C949FQ42111168-4E4017F4-920E-47B0-9A29-49D6EFB6DA93Q42757281-66D3384D-BA75-44FC-B607-BC72075904EEQ45360109-ECC453C4-D1D0-4FBF-94F1-0792EDBDB1B9Q46020642-D3924225-4A89-408E-A8D8-491AB9ADD9CEQ48181241-8960A967-608B-4578-A879-D5318838A391Q56833667-0AEC0D82-E59A-4863-B4BB-3D9785456905
P2860
Complexity in influenza virus targeted drug design: interaction with human sialidases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Complexity in influenza virus targeted drug design: interaction with human sialidases.
@ast
Complexity in influenza virus targeted drug design: interaction with human sialidases.
@en
type
label
Complexity in influenza virus targeted drug design: interaction with human sialidases.
@ast
Complexity in influenza virus targeted drug design: interaction with human sialidases.
@en
prefLabel
Complexity in influenza virus targeted drug design: interaction with human sialidases.
@ast
Complexity in influenza virus targeted drug design: interaction with human sialidases.
@en
P2093
P50
P356
P1476
Complexity in influenza virus targeted drug design: interaction with human sialidases
@en
P2093
Bruno Venerando
Guido Tettamanti
Jeffrey C Dyason
Leonard M G Chavas
Maretta C Mann
Mark von Itzstein
Nobuhiro Suzuki
Paola Fusi
Ryuichi Kato
Soichi Wakatsuki
P304
P356
10.1021/JM100078R
P407
P577
2010-04-01T00:00:00Z